151 related articles for article (PubMed ID: 37240223)
21. Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis.
Zekri A; Ghaffari SH; Yousefi M; Ghanizadeh-Vesali S; Mojarrad M; Alimoghaddam K; Ghavamzadeh A
Mol Cell Endocrinol; 2013 Sep; 377(1-2):84-92. PubMed ID: 23851143
[TBL] [Abstract][Full Text] [Related]
22. Effects of fatty acid synthase inhibitors on lymphatic vessels: an in vitro and in vivo study in a melanoma model.
Bastos DC; Paupert J; Maillard C; Seguin F; Carvalho MA; Agostini M; Coletta RD; Noël A; Graner E
Lab Invest; 2017 Feb; 97(2):194-206. PubMed ID: 27918556
[TBL] [Abstract][Full Text] [Related]
23. Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis.
McMahon GA; Petitclerc E; Stefansson S; Smith E; Wong MK; Westrick RJ; Ginsburg D; Brooks PC; Lawrence DA
J Biol Chem; 2001 Sep; 276(36):33964-8. PubMed ID: 11441025
[TBL] [Abstract][Full Text] [Related]
24. Growth and metastasis of B16-F10 melanoma cells is not critically dependent on host CD73 expression in mice.
Burghoff S; Gong X; Viethen C; Jacoby C; Flögel U; Bongardt S; Schorr A; Hippe A; Homey B; Schrader J
BMC Cancer; 2014 Dec; 14():898. PubMed ID: 25465225
[TBL] [Abstract][Full Text] [Related]
25. XR5967, a novel modulator of plasminogen activator inhibitor-1 activity, suppresses tumor cell invasion and angiogenesis in vitro.
Brooks TD; Wang SW; Brünner N; Charlton PA
Anticancer Drugs; 2004 Jan; 15(1):37-44. PubMed ID: 15090742
[TBL] [Abstract][Full Text] [Related]
26. ADAMTS4 and its proteolytic fragments differentially affect melanoma growth and angiogenesis in mice.
Rao N; Ke Z; Liu H; Ho CJ; Kumar S; Xiang W; Zhu Y; Ge R
Int J Cancer; 2013 Jul; 133(2):294-306. PubMed ID: 23319426
[TBL] [Abstract][Full Text] [Related]
27. The binding between the stem regions of human growth hormone (GH) receptor compensates for the weaker site 1 binding of 20-kDa human GH (hGH) than that of 22-kDa hGH.
Tsunekawa B; Wada M; Ikeda M; Banba S; Kamachi H; Tanaka E; Honjo M
J Biol Chem; 2000 May; 275(21):15652-6. PubMed ID: 10748003
[TBL] [Abstract][Full Text] [Related]
28. Anti-angiogenic effect of Biophytum sensitivum is exerted through its cytokine modulation activity and inhibitory activity against VEGF mRNA expression, endothelial cell migration and capillary tube formation.
Guruvayoorappan C; Kuttan G
J Exp Ther Oncol; 2007; 6(3):241-50. PubMed ID: 17552364
[TBL] [Abstract][Full Text] [Related]
29. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.
Gutierrez LS; Schulman A; Brito-Robinson T; Noria F; Ploplis VA; Castellino FJ
Cancer Res; 2000 Oct; 60(20):5839-47. PubMed ID: 11059781
[TBL] [Abstract][Full Text] [Related]
30. CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo.
Koch M; Hussein F; Woeste A; Gründker C; Frontzek K; Emons G; Hawighorst T
Breast Cancer Res Treat; 2011 Jul; 128(2):337-46. PubMed ID: 20714802
[TBL] [Abstract][Full Text] [Related]
31. Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment.
Heffernan MA; Thorburn AW; Fam B; Summers R; Conway-Campbell B; Waters MJ; Ng FM
Int J Obes Relat Metab Disord; 2001 Oct; 25(10):1442-9. PubMed ID: 11673763
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics.
Reiher FK; Volpert OV; Jimenez B; Crawford SE; Dinney CP; Henkin J; Haviv F; Bouck NP; Campbell SC
Int J Cancer; 2002 Apr; 98(5):682-9. PubMed ID: 11920636
[TBL] [Abstract][Full Text] [Related]
33. Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells.
Pandey V; Perry JK; Mohankumar KM; Kong XJ; Liu SM; Wu ZS; Mitchell MD; Zhu T; Lobie PE
Endocrinology; 2008 Aug; 149(8):3909-19. PubMed ID: 18450952
[TBL] [Abstract][Full Text] [Related]
34. Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis.
Leik CE; Su EJ; Nambi P; Crandall DL; Lawrence DA
J Thromb Haemost; 2006 Dec; 4(12):2710-5. PubMed ID: 17010152
[TBL] [Abstract][Full Text] [Related]
35. Limited proteolysis of human growth hormone at low pH: isolation, characterization, and complementation of the two biologically relevant fragments 1-44 and 45-191.
Spolaore B; Polverino de Laureto P; Zambonin M; Fontana A
Biochemistry; 2004 Jun; 43(21):6576-86. PubMed ID: 15157090
[TBL] [Abstract][Full Text] [Related]
36. Receptor binding properties and insulin-like effects of human growth hormone and its 20 kDa-variant in rat adipocytes.
Smal J; Closset J; Hennen G; De Meyts P
J Biol Chem; 1987 Aug; 262(23):11071-9. PubMed ID: 3301849
[TBL] [Abstract][Full Text] [Related]
37. Twenty-kilodalton human growth hormone (20K hGH) secretion from growth hormone-secreting pituitary adenoma cells in vitro.
Murakami Y; Mori T; Koshimura K; Kurosaki M; Takenobu A; Hashimoto Y; Kato Y
Endocr J; 2000 Oct; 47(5):563-8. PubMed ID: 11200936
[TBL] [Abstract][Full Text] [Related]
38. 22- and 20 kDa-human growth hormones bind to different sites within certain cellular receptors.
Longhi SA; Cortés MM; Retegui LA
Growth Horm IGF Res; 2003 Dec; 13(6):353-60. PubMed ID: 14624770
[TBL] [Abstract][Full Text] [Related]
39. Potential anticancer properties of the water extract of Inonotus [corrected] obliquus by induction of apoptosis in melanoma B16-F10 cells.
Youn MJ; Kim JK; Park SY; Kim Y; Park C; Kim ES; Park KI; So HS; Park R
J Ethnopharmacol; 2009 Jan; 121(2):221-8. PubMed ID: 19041933
[TBL] [Abstract][Full Text] [Related]
40. Mouse macrophage metalloelastase gene transfer into a murine melanoma suppresses primary tumor growth by halting angiogenesis.
Gorrin-Rivas MJ; Arii S; Furutani M; Mizumoto M; Mori A; Hanaki K; Maeda M; Furuyama H; Kondo Y; Imamura M
Clin Cancer Res; 2000 May; 6(5):1647-54. PubMed ID: 10815882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
